MedPath

广州合和医药有限公司

Ownership
-
Established
2022-09-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20254426
Approval Date
Jun 3, 2025
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20254263
Approval Date
May 27, 2025
NMPA

Calcium Chloride Injection

Product Name
氯化钙注射液
Approval Number
国药准字H20254084
Approval Date
May 13, 2025
NMPA

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20254114
Approval Date
May 13, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.